However, co-treatment with compound C significantly blocked the CT-mediated reduction in TG accumulation, but not Ex52735 (SIRT1 inhibitor), which suggested that AMPK, as an upstream of SIRT1, mediates CT-induced protection against ethanol-promoted hepatic steatosis. Here, SIRT1 is linked to fatty liver disease.